Country: Malta
Language: English
Source: Medicines Authority
folic acid 415 mg/ml
Alapis S.A.
B03BB01
folic acid
oral solution
Authorised
2011-04-05
PACKAGE LEAFLET: INFORMATION FOR THE USER FOLIC ACID ALAPIS 1MG/ML ORAL SOLUTION Folic acid READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Folic Acid Alapis is and what it is used for 2. Before you take Folic Acid Alapis 3. How to take Folic Acid Alapis 4. Possible side effects 5. How to store Folic Acid Alapis 6. Further information 1. WHAT FOLIC ACID ALAPIS IS AND WHAT IT IS USED FOR The name of your medicine is Folic Acid Alapis 1mg/ml oral solution. It contains folic acid. This belongs to a group of vitamins called ‘B vitamins’. Folic Acid Alapis is used for the prevention and treatme nt of conditions caused by deficiency of folic acid: 1. Prevention of neural tube defects (abnormalities of the spine, eg. spina bifida) in babies, including if you have previously had a baby with this disorder. 2. Prevention and treatment of anaemia caused by folic acid deficiency.This may occur in the following situations. a) pregnancy b) excessive alcohol intake or poor nutrition c) effects of other drugs (eg. anticonvulsants, used to prevent fits) d) sickle cell anaemia (or other types of anaemia caused by abnormal red blood cells) e) pr Read the complete document
Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Folic Acid Alapis 1mg/ml oral solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 1 mg of folic acid. It also contains sodium (26.1 mg per 15 ml). For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral solution. A pale yellow liquid with a strawberry odour. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1. For the prophylaxis of neural tube defects in case of a positive history of previous NTD. 2. For the prophylaxis of neural tube defects with no previous history of fetal neural tube defect and no other predisposing factors 3. For the treatment of folate deficiency: a. Folate deficient megaloblastic anaemia (in pregnancy, associated with alcoholism, drug intake such as anticonvulsants) (For the prevention of megaloblastic anemia the cobalamin status should be established before initiation of folic acid therapy). b. Impaired utilization such as use of concomitant drugs, in liver disease, inadequate intake (eg alcoholism, malnutrition etc) c. And in increased excretion (e.g. alcoholism, haemolytic states). 4. Folate deficiency / megaloblastic anaemia associated with hemolytic anemia (eg sickle cell anemia) 5. Treatment of folate deficiency in malabsorption syndromes (parenteral administration of folic acid may need to be considered if oral treatment is not effective) (eg.: tropical sprue. Tropical sprue responds to folate supplements in the early stages of the disease but cobalamin status must also be checked, particularly later; coeliac disease in which case the necessity of supplementation with folate ce Read the complete document